White Anne E.'s Form 4 filing
Eli Lilly & Co (LLY) · filed Feb 14, 2023
- Accession no.
- 0000059478-23-000069
- Filed
- Feb 14, 2023
- Trade date
- Feb 10-13, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.72M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| White Anne E.CIK 0001752313 | Officer (EVP & Pres, Lilly Neuroscience) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 10, 2023 | Common Stock | AGrant or awardAcquired | +8,562 | $345.12 | +$2,954,917.44 | 62,926 | Direct | |
| Feb 10, 2023 | Common Stock | SSaleDisposed | −2,500 | $342.76 | −$856,900 | 60,426 | Direct | |
| Feb 13, 2023 | Common Stock | SSaleDisposed | −2,500 | $346.47 | −$866,175 | 57,926 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 10, 2023 | Common Stock | AGrant or awardAcquired | +4,124 | $0.00 | $0 | 4,124 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.